ES8608922A1 - Un metodo para reducir el caracter laminar de una poblacion de liposomas - Google Patents

Un metodo para reducir el caracter laminar de una poblacion de liposomas

Info

Publication number
ES8608922A1
ES8608922A1 ES544364A ES544364A ES8608922A1 ES 8608922 A1 ES8608922 A1 ES 8608922A1 ES 544364 A ES544364 A ES 544364A ES 544364 A ES544364 A ES 544364A ES 8608922 A1 ES8608922 A1 ES 8608922A1
Authority
ES
Spain
Prior art keywords
liposomes
extrusion techniques
producing
producing liposomes
size distribution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES544364A
Other languages
English (en)
Spanish (es)
Other versions
ES544364A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of ES8608922A1 publication Critical patent/ES8608922A1/es
Publication of ES544364A0 publication Critical patent/ES544364A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/18—Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/08—Flat membrane modules

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Water Supply & Treatment (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
ES544364A 1984-06-20 1985-06-19 Un metodo para reducir el caracter laminar de una poblacion de liposomas Expired ES8608922A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62269084A 1984-06-20 1984-06-20
US62250284A 1984-06-20 1984-06-20

Publications (2)

Publication Number Publication Date
ES8608922A1 true ES8608922A1 (es) 1986-09-01
ES544364A0 ES544364A0 (es) 1986-09-01

Family

ID=27089214

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544364A Expired ES8608922A1 (es) 1984-06-20 1985-06-19 Un metodo para reducir el caracter laminar de una poblacion de liposomas

Country Status (11)

Country Link
EP (1) EP0185756B1 (2)
JP (1) JP2537186B2 (2)
CA (1) CA1264668A (2)
DE (1) DE3579426D1 (2)
DK (1) DK173397B1 (2)
ES (1) ES8608922A1 (2)
GR (1) GR851485B (2)
IE (1) IE58630B1 (2)
PT (1) PT80678B (2)
SG (1) SG21092G (2)
WO (1) WO1986000238A1 (2)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231112A (en) 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
US5897873A (en) * 1984-04-12 1999-04-27 The Liposome Company, Inc. Affinity associated vaccine
US5736155A (en) * 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
MX9203291A (es) * 1985-06-26 1992-08-01 Liposome Co Inc Metodo para acoplamiento de liposomas.
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
US4737323A (en) * 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US6759057B1 (en) 1986-06-12 2004-07-06 The Liposome Company, Inc. Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US6406713B1 (en) 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
WO1988007850A1 (en) * 1987-04-16 1988-10-20 The Liposome Company, Inc. Liposome continuous size reduction method and apparatus
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
WO1988009170A1 (en) * 1987-05-22 1988-12-01 The Liposome Company, Inc. Prostaglandin-lipid formulations
MX9203804A (es) * 1987-10-19 1992-07-01 Liposome Co Inc Sistemas farmaceuticos a base de tocoferol.
US5948441A (en) * 1988-03-07 1999-09-07 The Liposome Company, Inc. Method for size separation of particles
DE3812816A1 (de) * 1988-04-16 1989-11-02 Lawaczeck Ruediger Dipl Phys P Verfahren zur solubilisierung von liposomen und/oder biologischer membranen sowie deren verwendung
JPH04501723A (ja) * 1988-11-09 1992-03-26 アンガー，エヴァン，シー． リポソーム性放射線造影剤
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
CA2058940C (en) * 1989-06-23 2000-05-09 Helen Loughrey Targeted liposomes and methods for liposome-protein coupling
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5149319A (en) * 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
US5525232A (en) * 1990-03-02 1996-06-11 The Liposome Company, Inc. Method for entrapment of cationic species in lemellar vesicles
AU660288B2 (en) * 1990-07-31 1995-06-22 Transave, Inc. Accumulation of amino acids and peptides into liposomes
US6623671B2 (en) 1990-10-05 2003-09-23 Royden M. Coe Liposome extrusion process
ES2087315T3 (es) * 1990-10-05 1996-07-16 Liposome Co Inc Procedimiento de extrusion de liposomas.
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
EP1104678A2 (en) 1992-05-04 2001-06-06 UNGER, Evan C Method for hyperthermic potentiation of tissue
JPH08505312A (ja) * 1992-10-16 1996-06-11 ザックセ，アンドレアス 液状分散系を製造する方法及び装置
EP0699068B1 (en) * 1993-05-21 2001-12-19 The Liposome Company, Inc. Reduction of liposome-induced adverse physiological reactions
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US5716526A (en) * 1994-01-14 1998-02-10 The Liposome Company, Inc. Method of separating materials from liposomes or lipid complexes
US5622715A (en) * 1994-06-10 1997-04-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of improving renal function
US6235308B1 (en) 1994-06-10 2001-05-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating hypertension
DE19515163C2 (de) * 1995-01-31 2002-11-28 Erich Politsch Vorrichtung zur Extrusion von Suspensionen
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
NL1001380C2 (nl) * 1995-10-09 1997-04-11 Fuji Photo Film Bv Methode voor het dispergeren van een geëmulgeerd materiaal van het olie-druppeltype in een vloeistoftoevoersysteem en bekledingsmethode waarbij van een dergelijke dispergeermethode gebruik wordt gemaakt.
HUP9801834A3 (en) 1995-10-12 2000-06-28 Supergen Inc Emeryville Liposome formulations of 5beta steroids
DE19542499A1 (de) 1995-11-15 1997-05-22 Bayer Ag Verfahren und Vorrichtung zur Herstellung einer parenteralen Arzneistoffzubereitung
WO1997040679A1 (en) 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
IT1289939B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
ATE409495T1 (de) 2001-04-04 2008-10-15 Nordic Vaccine Technology As Polynukleotide-bindende komplexe die sterolen und saponine enthalten
PT1560641E (pt) 2002-11-14 2006-07-31 Leuven K U Res & Dev Metodo para a preparacao de emulsoes
JP2005170923A (ja) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法
JP2005170928A (ja) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法
JP4654590B2 (ja) * 2004-03-31 2011-03-23 コニカミノルタエムジー株式会社 Ｘ線ｃｔ用造影組成物およびその製造方法
ES2641272T3 (es) 2006-04-28 2017-11-08 Children's Hospital Medical Center Composiciones que comprenden proteínas o polipéptidos fusogénicos derivados de la prosaposina para aplicación en sistemas de suministro de fármacos transmembrana
KR20080012605A (ko) 2006-08-04 2008-02-12 삼성에스디아이 주식회사 탄성 에너지 장벽을 이용한 생체막 소자
EP1920765A1 (en) * 2006-11-07 2008-05-14 Medigene AG Liposome preparation by single-pass process
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5771366B2 (ja) 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
CN103328038A (zh) 2010-12-01 2013-09-25 史拜诺莫度雷森公司 向神经解剖结构直接递送药剂
JP2015509085A (ja) 2012-01-01 2015-03-26 キュービーアイ エンタープライゼズ リミテッドＱｂｉ Ｅｎｔｅｒｐｒｉｓｅｓ Ｌｔｄ． 治療剤および診断剤の選択的送達のためのｅｎｄｏ１８０を標的とする粒子
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
ES2685581T3 (es) * 2013-03-14 2018-10-10 Biorest Ltd. Formulación y fabricación de liposomas
WO2018005657A1 (en) * 2016-06-28 2018-01-04 Verily Life Sciences Llc Serial filtration to generate small cholesterol-containing liposomes
JP6403026B2 (ja) * 2017-06-29 2018-10-10 バイオレスト リミテッド リポソーム、リポソームを含む処方剤、および処方剤の製造方法
CA3084821A1 (en) 2017-12-15 2019-06-20 Board Of Regents, The University Of Texas System Methods and compositions for treating cancer using exosomes-associated gene editing
EP3775258A4 (en) 2018-03-28 2022-01-26 Board of Regents, The University of Texas System IDENTIFICATION OF EPIGENETIC ALTERATIONS IN DNA ISOLATED FROM EXOSOMES
JP6596648B2 (ja) * 2018-08-29 2019-10-30 ズーリー ホールディングス リミテッド リポソーム、リポソームを含む処方剤、および処方剤の製造方法
WO2024175457A1 (en) * 2023-02-23 2024-08-29 Evonik Operations Gmbh Small scale liposome extruder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
JPS5782310A (en) * 1980-11-11 1982-05-22 Tanabe Seiyaku Co Ltd Production of liposome preparation

Also Published As

Publication number Publication date
CA1264668C (en) 1990-01-23
DK173397B1 (da) 2000-09-18
EP0185756A4 (en) 1987-09-02
PT80678B (pt) 1987-08-19
WO1986000238A1 (en) 1986-01-16
DE3579426D1 (de) 1990-10-04
DK77986A (da) 1986-02-19
EP0185756B1 (en) 1990-08-29
ES544364A0 (es) 1986-09-01
DK77986D0 (da) 1986-02-19
IE58630B1 (en) 1993-10-20
PT80678A (en) 1985-07-01
CA1264668A (en) 1990-01-23
JP2537186B2 (ja) 1996-09-25
JPS61502452A (ja) 1986-10-30
EP0185756A1 (en) 1986-07-02
IE851514L (en) 1985-12-20
GR851485B (2) 1985-11-25
SG21092G (en) 1992-04-16

Similar Documents

Publication Publication Date Title
ES8608922A1 (es) Un metodo para reducir el caracter laminar de una poblacion de liposomas
AU580643B2 (en) Retroreflective particles and methods for their production and use
DE68926758D1 (de) Abriebfeste gesinterte Eisenlegierung, bestehend aus einer Dispersion von harten Legierungsteilchen und Verfahren zu ihrer Herstellung
IT1185298B (it) Gruppo di estrusione per l'estrusione di materia sintetica termoplastificata
CA2166465A1 (en) Method of controlling the size of liposomes
GB2086870B (en) High performance carbon fiber process for production thereof and composite materials prepared therewith
AU2448984A (en) Sorting particles according to melting point
GB8312436D0 (en) Producing composite articles
EP0334478A3 (en) Die-upset manufacture to produce high volume fractions of re-fe-b type magnetically-aligned material
GB8425961D0 (en) Producing fine fibres
IT8149760A0 (it) Dibenzazepine loro preparazione eloro impiego come medicamenti
DE3175184D1 (en) 2,3-butanediol diester derivatives, process for producing the same, and an antiulcer drug containing the same
DE3161409D1 (en) 2,4-dialkyl-2,6-heptadienals and -hetadienols, process for their preparation and their use as perfume compounds and flavourings
AU518241B2 (en) Production of particulate resoles
DE3752106D1 (de) Herstellung von Katalysatorteilchen sortiert nach Dichte
JPS5596095A (en) Composite particle group containing active protein substance * production * use and regeneration thereof
HUT47796A (en) Herbicide compositions containing new 2-substituted imino-1,3,4-dihydro-thiadiazols as active components and process for producing the active components
IL73896A (en) Silane-modified ester mixtures,their production and pharmaceutical and cosmetic compositions containing them
GB8818794D0 (en) Production of intermetallic particles & products including such
EP0043507A3 (en) 2,4-dioxa-7,10 methano-spiro(5,5)undecanes, their preparation as well as perfume compositions containing them
IL61223A (en) Tricyclo(6.2.1.0 1,6)undecanes,their preparation and perfume compositions containing them
DE3373472D1 (en) Acryloyloxy groups containing 1,3-dioxane derivatives, and process for producing them
ZA839343B (en) Process for the production of dihydrocarbyl carbonates,their use as fuel additives and fuel compositions containing them
ZA807943B (en) New pyrrolobenzotriazepines,their production and pharmaceutical compositions containing them
EP0137426A3 (de) Neue 2-Mercaptothiazolderivate, Verfarhen zu deren Herstellung sowie die Verwendung von 2-Mercaptothiazolderivaten in Arzneimitteln

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060605